Table 2 Characteristics of evaluable patients
ID | Cohort | Age | Sex | Racea | Primary Tumor Type | Prior Treatmentsb |
|---|---|---|---|---|---|---|
1 | 1 | 63 | M | NA | Pancreas | 3 |
2 | 34 | M | NA | Colon | 6 | |
3 | 62 | F | C | Lung | 5 | |
4 | 2 | 57 | F | C | Melanoma (Ocular) | 1 |
5 | 27 | M | C | Thymic | 3 | |
6 | 44 | F | C | Breast | 12 | |
7 | 3 | 66 | F | C | Melanoma (Cutaneous) | 1 |
8 | 70 | F | C | Melanoma (Cutaneous) | 1 | |
9 | 70 | M | C | Melanoma (Cutaneous) | 1 | |
10 | 4 | 43 | F | C | Breast | 7 |
11 | 59 | F | C | Melanoma (Ocular) | 0 | |
12 | 57 | M | C | Melanoma (Cutaneous) | 5 | |
13 | 81 | F | C | Melanoma (Ocular) | 0 | |
14 | 57 | F | C | Breast | 6 | |
15 | 61 | F | A | Breast | 9 | |
16 | 53 | F | C | Breast | 6 |